Analysts expect Prothena Corp to report an earnings per share (EPS) of $-1.03. The announcement from Prothena Corp is eagerly ...

After a long career as an accomplished TV and radio journalist for programs like AM, This Day Tonight and Beyond 2000, Iain ...

The journalist’s organs had been severely damaged by the disease, which causes a buildup of amyloid proteins in the body.

The European Medicines Agency has recommended marketing approval for Alyftrek for cystic fibrosis and Attrogy for a form of hereditary amyloidosis.

A new FDA-approved ATTR-CM treatment is giving new hope to patients — especially older Black Americans who are at high risk ...

Fortress Biotech, Inc.’s FBIO share price has dipped by 6.18%, which has investors questioning if this is right time to buy.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNA interference (RNAi) therapeutics company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...

Weight: Under 11 pounds (mini), 16–32 pounds (standard) ...

The following is a summary of “Elevated serum concentrations of GFAP in hereditary transthyretin amyloidosis since pre-symptomatic stages,” published in the April 2025 issue of Journal of Neurology by ...